Dmitry V Zaretsky Selected Research

Dimenhydrinate (DMH)

1/2018	Disinhibiting neurons in the dorsomedial hypothalamus delays the onset of exertional fatigue and exhaustion in rats exercising in a warm environment.
5/2015	Treadmill running restores MDMA-mediated hyperthermia prevented by inhibition of the dorsomedial hypothalamus.
4/2014	Inhibition of the dorsomedial hypothalamus, but not the medullary raphe pallidus, decreases hyperthermia and mortality from MDMA given in a warm environment.
12/2012	The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress.
3/2008	Induction of Fos-immunoreactivity in the rat brain following disinhibition of the dorsomedial hypothalamus.
10/2007	Stress- and lipopolysaccharide-induced c-fos expression and nNOS in hypothalamic neurons projecting to medullary raphe in rats: a triple immunofluorescent labeling study.
1/2007	The dorsomedial hypothalamus: a new player in thermoregulation.
6/2006	Stress-induced cardiac stimulation and fever: common hypothalamic origins and brainstem mechanisms.
4/2003	Role of the dorsomedial hypothalamus in thermogenesis and tachycardia caused by microinjection of prostaglandin E2 into the preoptic area in anesthetized rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dmitry V Zaretsky Research Topics

Disease

9	Hyperthermia 01/2018 - 04/2003
9	Tachycardia (Tachyarrhythmias) 10/2015 - 01/2003
4	Fever (Fevers) 03/2008 - 06/2006
3	Hypertension (High Blood Pressure) 10/2015 - 08/2008
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2020
2	Fatigue 01/2018 - 01/2014
2	Hypothermia 10/2015 - 11/2007
1	Mental Disorders (Mental Disorder) 07/2017
1	Inflammation (Inflammations) 10/2007
1	Infarction (Infarctions) 02/2004

Drug/Important Bio-Agent (IBA)

9	Dimenhydrinate (DMH)FDA LinkGeneric 01/2018 - 04/2003
5	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 05/2015 - 11/2007
3	MuscimolIBA 01/2007 - 01/2003
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2020
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 10/2015 - 11/2007
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2014 - 12/2012
2	Pharmaceutical PreparationsIBA 08/2008 - 11/2007
2	GABA-A Receptor AgonistsIBA 01/2007 - 01/2003
1	Amyloid beta-PeptidesIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Ion Channels (Ion Channel)IBA 01/2020
1	Corticotropin-Releasing HormoneIBA 07/2017
1	Yohimbine (Yocon)IBA 10/2015
1	AmphetaminesIBA 10/2014
1	Methamphetamine (Desoxyn)FDA LinkGeneric 04/2014
1	Performance-Enhancing SubstancesIBA 01/2014
1	bicuculline methiodideIBA 03/2008
1	Serotonin (5 Hydroxytryptamine)IBA 11/2007
1	5-HT1A Serotonin ReceptorIBA 11/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2007
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2007
1	Prostaglandins EIBA 01/2007
1	Dinoprostone (PGE2)FDA Link 04/2003

Therapy/Procedure

1	Aftercare (After-Treatment) 11/2007
1	Induced Hypothermia 11/2007
1	Ligation 02/2004